Increased prominence of nanoproteins gaining traction due to the high prevalence of cancer and associated genetic disorders leading to growth

DublinAnd January 21, 2023 /PRNewswire/ – Research and Markets

the “Global Proteomics Market: Analysis by Product, by Application, by Technology, by End User, by Region Size and Forecast with COVID-19 Impact Analysis and Forecast to 2027” The report has been added to an offer.

In 2021, the global protein market has been assessed $24.98 billionis likely to arrive $95.29 billion By 2027.

The protein market is expected to grow at a CAGR of 25% during the forecast period 2022-2027.

Technological advances, increased funding for research, rising healthcare costs, growing demand for tailor-made drugs, and rising rates of genetic diseases are also expected to drive the growth of the market over the coming years.

Proteomics is the study of proteins involved in disease and their structure, function, and expression. It helps in understanding the process and interactions of the whole protein content of an organism. Proteomic research also identifies warning signs and provides diagnostics for infectious diseases such as malaria and cancer. Proteomics are also used in the pharmaceutical industry to investigate the mechanism of action or toxicity of a drug, as well as to identify and validate the efficacy of biomarkers.

Market Segmentation Analysis:

The reagents segment captured the majority of the market share in 2021, due to the heavy use of reagents, consumables, kits, chemicals and strips for examining various biological samples in academic institutions, research laboratories, etc., which will increase the demand for reagents and consumables fueling the growth of the sector. The sector itself is expected to have the highest CAGR in the future due to technological developments of advanced instruments, such as 2D electrophoresis protein analyzers.

The drug discovery segment captured the majority of the market share in 2021, due to the development of structure-based drug design, greater emphasis on custom drug creation, and more investments in these areas can be credited with the growth of this segment.

The drug discovery segment is expected to have the highest CAGR in the future due to proteomics technologies also providing a way to emerge early in the drug discovery program, saving pharmaceutical companies a great deal of capital and ultimately benefiting patients as well as healthcare systems.

In 2021, the protein arrays segment retained the maximum market share, due to the high use of this technology to track protein interactions in less time compared to other technologies. Also, protein microarrays are expected to have the highest CAGR in the future because this method is labor intensive and cost effective.

In 2021, the pharmaceutical companies segment captured the maximum market share, due to the increase in R&D investments made by companies in the field of genomics and proteomics. However, academic research laboratories are expected to have the highest compound annual growth rate in the future due to increased government support for clinical research projects.

the North Amarica The protein market enjoyed the highest market share in 2021, mainly due to increasing popularity and adoption of personalized drugs, favorable government funding, and initiatives to develop new therapies.

While the United States remains a prominent region in North Amarica Protein market, which is an increase in the awareness and use of proteomics and technological advances contribute significantly to the growth of the market in the region.

Dynamics of the global protein market:

Growth drivers:

Increasing investment in biotechnology companies in 2020 has supported the development of the protein market. The pandemic has negatively affected most sectors, including healthcare. However, publicly traded biotech companies have seen growth in investment in March 2020 After the first random shock in stock prices. This is a positive sign for the protein market.

Further, the market is expected to increase due to higher prevalence of cancer and associated genetic disorder, faster turn-over times (tat), increasing investments in research and development in the field of proteins, accessibility and reproduction, etc.


Companies rely on publicly available structure data and trial-and-error methods to identify compounds that either stimulate or inhibit target proteins. Protein structure requires the use of fast, highly productive tools and machinery. All of these procedures require a large number of laboratory hours, which raises the testing costs per sample. Other challenges faced by the proteins market are dynamic range, PTM blows up the level of complexity in proteins, high cost of tooling, etc.


A major trend that is gaining pace in the protein market is artificial intelligence in proteomics. Applications of artificial intelligence (AI) in proteins are already reshaping the drug discovery landscape. Understanding how and why specific proteins interact is critical to advancing cell biology, developing new drugs, and determining how drugs can have both therapeutic and harmful effects.

Further market trends believed to fuel the growth of the proteins market over the forecast period include increase in drug discovery, emerging method: high platelet proteins, emerging technologies, increasing prominence of nanoproteins and new applications based on protein technology developments, etc.

Analyzing the impact of COVID-19 moving forward:

Due to the COVID-19 pandemic, some clinical studies around the world have been temporarily delayed. The pandemic created a lot of demand for protein services, which had a huge impact on the market. There is continued interest in using advanced mass spectrometry to improve quality outcomes for patients. In 2020, new technologies in mass spectrometers have allowed proteins unique to COVID-19 to be identified. The protein industry has seen positive growth during the pandemic.

Competitive landscape and recent developments:

Major players are constantly investing in strategic initiatives, such as launching new products, introducing their products to emerging markets and more, to maintain a competitive edge in this market.

The protein market is concentrated with a few dominant players mainly worldwide.

The major players in the protein market are:

  • Danaher Corporation

  • Agilent Technologies

  • PerkinElmer, Inc.

  • Bio-Rad Laboratories, Inc.

  • Thermo Fisher Scientific Inc.

  • Broker Company

  • Illumina Corporation

  • Horiba, Ltd.

  • water company

  • DiaSorin SpA (Luminex Corporation)

  • Promega Corporation

Main topics covered:
1. Executive summary
2. Introduction
2.1 Proteomics: An Overview
2.1.1 Overview of Proteomics
2.1.2 Characteristics of existing proteomics technologies
2.2 Fragmentation of proteins: an overview
2.2.1 Fragmentation of proteins
3. Global market analysis
3.1 Global Proteomics Market: Analysis
3.2 Global Proteomics Market: Product Analysis
3.3 Global Protein Market: Application Analysis
3.4 Global Proteomics Market: Technology Analysis
3.4.8 Global Proteomics Market by Value
3.5 Global Proteomics Market: End Users Analysis
3.5.6 Global Polypeptides Market to End Users by Value
4. Regional market analysis
4.1 North America Protein Protein Market: Analysis
4.2 Europe Proteins Market: Analysis
4.3 Asia Pacific Protein Market: Analysis
4.4 Rest of the World Proteins Market: Analysis
5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Protein Market
5.1.2 After the impact of COVID-19
6. Market dynamics
6.1 The engine of growth
6.1.1 High prevalence of cancer and associated genetic disorders
6.1.2 Faster turnaround times (TAT)
6.1.3 Growth of investments in biotech companies
6.1.4 Increasing investments in research and development in the field of proteins
6.1.5 Accessibility and Reproducibility
6.2 Challenges
6.2.1 Dynamic Range
6.2.2 High cost of tools
6.2.3 PTMs explode the level of complexity in proteins
6.3 Market Trends
6.3.1 AI in Proteomics
6.3.2 Increase in drug discovery
6.3.3 Emerging method: platelet-high proteins
6.3.4 Emerging Technologies
6.3.5 Increased prominence of nanoproteins
6.3.6 New applications based on advances in protein technology
7. The competitive landscape
7.1 Global Proteomics Market Players: Technology Comparison
8. Company profiles
8.1 Business Overview
8.2 Operating Segments
8.3 Business Strategy

For more information on this report visit

About is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, major companies, new products and the latest trends.

Media contact:

Laura Wood | +353-1-481-1716 |



View original content: Cancer and associated genetic disorders drive growth 301726777.html

SOURCE Research and Markets

Leave a Comment